CY1115564T1 - METHODS OF HEALTH LOSS TREATMENT TREATMENT - Google Patents
METHODS OF HEALTH LOSS TREATMENT TREATMENTInfo
- Publication number
- CY1115564T1 CY1115564T1 CY20141100744T CY141100744T CY1115564T1 CY 1115564 T1 CY1115564 T1 CY 1115564T1 CY 20141100744 T CY20141100744 T CY 20141100744T CY 141100744 T CY141100744 T CY 141100744T CY 1115564 T1 CY1115564 T1 CY 1115564T1
- Authority
- CY
- Cyprus
- Prior art keywords
- glutathione
- treatment
- hearing loss
- methods
- compositions comprise
- Prior art date
Links
Abstract
Σε μία εκδοχή, η παρούσα εφεύρεση παρέχει ωτοπροστατευτικές συνθέσεις χρήσιμες στη βελτίωση της απώλειας ακοής. Σε κάποιες εφαρμογές, οι ωτοπροστατευτικές συνθέσεις περιλαμβάνουν τουλάχιστον ένα μιμητικό υπεροξειδάσης της γλουταθειόνης. Σε κάποιες εφαρμογές, οι ωτοπροστατευτικές συνθέσεις περιλαμβάνουν τουλάχιστον ένα μιμητικό υπεροξειδάσης της γλουταθειόνης και τουλάχιστον ένα ωτοπροστατευτικό που επιλέγεται από την ομάδα που περιλαμβάνει αναστολέα οξειδάσης της ξανθίνης και γλουταθειόνη ή πρόδρομο γλουταθειόνης. Σε κάποιες εφαρμογές, οι ωτοπροστατευτικές συνθέσεις περιλαμβάνουν τουλάχιστον ένα μιμητικό υπεροξειδάσης της γλουταθειόνης, τουλάχιστον έναν αναστολέα οξειδάσης της ξανθίνης, τουλάχιστον μία γλουταθειόνη ή έναν πρόδρομο γλουταθειόνης. Σε άλλη εκδοχή, η παρούσα εφεύρεση παρέχει μεθόδους βελτίωσης της απώλειας ακοής με χορήγηση σε ασθενή ποσότητας ωτοπροστατευτικής σύνθεσης, που είναι αποτελεσματική για τη βελτίωση της απώλειας ακοής.In one embodiment, the present invention provides ear protective compositions useful in improving hearing loss. In some applications, the protective compositions comprise at least one glutathione peroxidase mimetic. In some embodiments, the otoprotective compositions comprise at least one glutathione peroxidase mimetic and at least one otoprotective agent selected from the group comprising xanthine oxidase inhibitor and glutathione or glutathione precursor. In some embodiments, the protective compositions comprise at least one glutathione peroxidase mimetic, at least one xanthine oxidase inhibitor, at least one glutathione or a glutathione precursor. In another embodiment, the present invention provides methods of improving hearing loss by administering to a patient an amount of self-protective composition, which is effective in improving hearing loss.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34581302A | 2002-01-04 | 2002-01-04 | |
EP03701231.7A EP1471902B1 (en) | 2002-01-04 | 2003-01-03 | Compositions for use in methods for treating hearing loss |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115564T1 true CY1115564T1 (en) | 2017-01-04 |
Family
ID=58461559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100744T CY1115564T1 (en) | 2002-01-04 | 2014-09-15 | METHODS OF HEALTH LOSS TREATMENT TREATMENT |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1115564T1 (en) |
-
2014
- 2014-09-15 CY CY20141100744T patent/CY1115564T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119601T1 (en) | PROTECTION PROMOTIONS | |
CY1117217T1 (en) | COMPOSITION AND ANTI-VISUAL ACTIVITY OF SUBSTITUTED AZAIDOLOOXOXIC PRODUCERS OF Piperazine | |
CY1116992T1 (en) | METHOD OF TREATMENT OF STRENGTHENING ILL-17 ACTIVITY | |
DE60312017D1 (en) | SULPHONE DERIVATIVES FOR INHIBITING GAMMA SECRETASE | |
CY1111613T1 (en) | METHODS FOR TREATMENT OF HIV INFECTION | |
CY1116784T1 (en) | Antimicrobial compounds and methods for their use | |
CY1115745T1 (en) | COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF OXALIC DISEASES | |
HUP0101594A2 (en) | Use of parathormone for increasing bone toughness and stiffness and reducing fractures | |
DE50213462D1 (en) | COATING OF STENTS TO PREVENT RESTENOSIS | |
CY1111246T1 (en) | PREVENTION AND TREATMENT OF INFLAMMATORY AND / OR IMMUNIATED BONE LOSS | |
CY1105386T1 (en) | BENZYLSULFONAMIDES AND SULFONYLBENZAMIDINES FOR USE AS ANTI-BULK AGENTS | |
UY26380A1 (en) | FAB I INHIBITORS | |
DE50310516D1 (en) | Fredericamycin DERIVATIVES | |
CY1113194T1 (en) | COMPOSITION AND ANTI-ACTIVITY OF SUBSTITUTED AZAIDOLOLOXOXIC PRODUCERS OF SUBSTITUTE | |
CY1110385T1 (en) | Use of IL-18 inhibitors for the treatment and / or prevention of atherosclerosis | |
EA200601553A1 (en) | SUBSTITUTED BENZIMIDAZOLE-, BENZTRIASOLE- AND BENZIMIDAZOLONE-O-GLUCOSIDES | |
CY1113963T1 (en) | PHARMACEUTICAL COMPOSITIONS WHICH INCLUDE ACTIVIA-COMPETITORS AND USE THESE IN PREVENTION OR MULTIPLE | |
EE200300440A (en) | Combination of epothilone analogues and chemotherapeutic agents for the treatment of proliferative diseases | |
CY1107383T1 (en) | SUSPENSIONS OF PHYSOLOGY SOLUTION A2 | |
PA8567001A1 (en) | ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS | |
CY1107985T1 (en) | CCR1 competitors for the treatment of other degenerative inflammatory diseases | |
CY1119317T1 (en) | COMPOSITION FOR LOCAL APPLICATION, USE OF THESE, APPLIANCES AND PART KITS | |
EA200401341A1 (en) | APPLICATION OF OSTEOPROTEGERIN FOR THE TREATMENT AND / OR PREVENTION OF FIBROUS DISEASE | |
ATE400577T1 (en) | ANNATED DIHYDROPYRANS | |
CY1113789T1 (en) | COMBINATIONS FROM potassium channel actuators and sodium channel blockers or active substances affecting sodium channel transducers |